Andreas Andersen
Overview
Explore the profile of Andreas Andersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kofod D, Diederichsen S, Bomholt T, Andersen M, Andersen A, Mannheimer E, et al.
Diabetologia
. 2025 Feb;
PMID: 40019498
Aims/hypothesis: We aimed to examine arrhythmias and hypoglycaemia among individuals with and without diabetes who are receiving haemodialysis and to investigate the association between arrhythmias and hypoglycaemia, hyperglycaemia and glycaemic...
2.
Kornerup N, Danielsen J, Sahl R, Pico M, Johansen M, Knop F, et al.
BMJ Open
. 2025 Jan;
15(1):e087895.
PMID: 39863406
Introduction: The global prevalence of people living with overweight has tripled since 1975 and more than 40% of Danish women enter pregnancy being overweight. With the increasing rates of obesity...
3.
Spona D, Frodi D, Xing L, Kongebro E, Haugan K, Graff C, et al.
J Clin Endocrinol Metab
. 2024 Sep;
PMID: 39231015
Purpose: Subclinical thyroid dysfunction is a marker for atrial fibrillation (AF) and stroke risk. This study explored the effects of AF screening according to thyroid-stimulating hormone (TSH) levels. Methods: An...
4.
Maytham K, Hagelqvist P, Engberg S, Forman J, Pedersen-Bjergaard U, Knop F, et al.
Front Endocrinol (Lausanne)
. 2024 Apr;
15:1352829.
PMID: 38686202
Background: Hypoglycemia is common in individuals with type 1 diabetes, especially during exercise. We investigated the accuracy of two different continuous glucose monitoring systems during exercise-related hypoglycemia in an experimental...
5.
Hagelqvist P, Andersen A, Maytham K, Andreasen C, Engberg S, Pedersen-Bjergaard U, et al.
J Clin Endocrinol Metab
. 2024 Apr;
109(11):2735-2744.
PMID: 38642404
Context: People with type 1 diabetes (T1D) are at increased risk of thrombosis compared to the general population; however, the underlying mechanisms remain unclear. Hypoglycemia induced at rest can induce...
6.
Andreasen C, Andersen A, Vilsboll T
Diabetologia
. 2023 Jul;
66(10):1846-1858.
PMID: 37498367
In the last few decades, glucagon-like peptide-1 receptor (GLP-1R) agonists have changed current guidelines and improved outcomes for individuals with type 2 diabetes. However, the dual glucose-dependent insulinotropic polypeptide receptor...
7.
Hagelqvist P, Andersen A, Maytham K, Andreasen C, Engberg S, Lindhardt T, et al.
Diabetes Obes Metab
. 2023 May;
25(8):2300-2309.
PMID: 37203283
Aim: To investigate the impact of hypoglycaemia, hyperglycaemia and glycaemic variability on arrhythmia susceptibility in people with type 1 diabetes. Materials And Methods: Thirty adults with type 1 diabetes were...
8.
Larsen E, Andersen A, Kjaer L, Eickhoff M, Frimodt-Moller M, Persson F, et al.
Free Radic Res
. 2023 May;
57(2):140-151.
PMID: 37171199
Animal studies have shown that SGLT2 inhibition decreases oxidative stress, which may explain the cardiovascular protective effects observed following SGLT2 inhibition treatment. Thus, we investigated the effects of two and...
9.
Haedersdal S, Andersen A, Knop F, Vilsboll T
Nat Rev Endocrinol
. 2023 Mar;
19(6):321-335.
PMID: 36932176
Insulin and glucagon exert opposing effects on glucose metabolism and, consequently, pancreatic islet β-cells and α-cells are considered functional antagonists. The intra-islet hypothesis has previously dominated the understanding of glucagon...
10.
Andreasen C, Andersen A, Hagelqvist P, Maytham K, Lauritsen J, Engberg S, et al.
Diabetes Obes Metab
. 2023 Feb;
25(6):1566-1575.
PMID: 36752677
Aim: To investigate changes in cardiac repolarization abnormalities (heart rate-corrected QT [QT ] [primary endpoint], T-wave abnormalities) and heart-rate variability measures in people with type 1 diabetes during insulin-induced hypoglycaemia...